Your selection
Research, Innovation, Patient care, Education / 18.06.2025
Students from Freie Universität Berlin visited the Campus Berlin-Buch
Visiting the Campus Berlin-Buch: Master's students in Biology at Freie Universität Berlin learned about career opportunities and start-ups at the BiotechPark Berlin-Buch on June 11, 2025.
During a tour of the campus with Campus Manager Dr. Ulrich Scheller, they were first given an overview of the closely cooperating research institutions and biotech companies as well as the location of future innovation Berlin-Buch, whose profile focuses on biomedicine and health.
Dr. Uwe Lohmeier, Head of the Berlin BioScience Academy, and Trendelina Rrustemi, Senior Scientist at Alithea Biotechnology GmbH, gave an insight into their career paths at the Career Panel Talk in the BerlinBioCube start-up center building. Dr. Lohmeier explained the development opportunities offered by the Berlin BioScience Academy (BBA).
Trendelin Rrustemi presented her start-up Alithea Biotechnology GmbH. It offers pioneering HLA peptide characterization with innovative immunopeptidomics, highly sensitive mass spectrometry and applied AI.
The students were then given an insight into the start-ups CUTANEON - Skin & Hair Innovations GmbH, Cultimate Foods GmbH and FyoniBio GmbH
The BiotechPark on the Campus Berlin-Buch is one of the leading technology parks in Germany. Buch has been renowned for its clinics and cutting-edge research for around 100 years and is now one of the largest biomedical locations in Germany.
The Berlin BioScience Academy (BBA), formerly known as "Gläsernes Labor Akademie (GLA)", supports young scientists throughout Germany in their professional orientation and entry into the pharmaceutical and biotechnology industry.
www.glaesernes-labor-akademie.de
Overview News
News Buch Berlin
Eckert & Ziegler Achieves Further Earnings Growth and Double-Digit Sales Growth in the Medical Segment
Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) increased sales in the first nine months of 2025 by 4% to €224.1 million compared to the same period last year. EBIT before special items from continuin...
more ...T-knife Therapeutics Presents Preclinical Data on PRAME-Targeted TK-6302 Highlighting its Potential as a Promising, Category-leading Therapy
Comprehensive TK-6302 data demonstrate preclinical efficacy and safety, supporting clinical readiness, alongside established scalable manufacturing. TK-6302 Clinical Trial Application planned in Q4 20...
more ...Why APOE4 raises Alzheimer’s risk
Researchers at the Max Delbrück Center and Aarhus University have found a mechanism through which the gene variant APOE4, long linked to a high risk of developing Alzheimer’s disease, impairs neuronal...
more ...Events Buch Berlin
16.12.2025, 15:30
Weihnachtliche Führung durch die einzigartige Sammlung historischer Mikroskope auf dem Campus Berlin-Buch
Lernen Sie die Anfänge der Berliner Mikroskop-Produktion und ihren Einfluss auf die moderne Biomedizin kennen - unter anderem auf die medizinische Forschung in Berlin-Buch!
more ...16.12.2025, 16:30
Invitation: Christmas tour of the unique collection of historical microscopes on the Campus Berlin-Buch
Discover the beginnings of Berlin’s microscope production and its influence on modern biomedicine. Neuroscientist Prof. Dr. Helmut Kettenmann will guide you through the microscope exhibition at the Ma...
more ...06.01.2026, 16:00
Vorlesung und Lehrerfortbildung: "Wenn das Immunsystem das Gehirn angreift – Autoimmunerkrankungen des zentralen Nervensystems"
Vorlesungsreihe: Neue Wege in der Biomedizin: Aktuelle Forschungsthemen vom Campus Berlin-Buch. Für Lehrkräfte, Schülerinnen und Schüler sowie Interessierte.
more ...
